Rothman KJ. Modern Epidemiology. Boston: Little, Brown & Co., 1996.
Oh, S. Clinical Electromyography. Baltimore, MD: University Park, 1984.
Dyck PJ, Kratz KM, Lehman JL, et al. The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 1991;41:799–807.
Franklin GM, Kahn LB, Baxter J, Marshall JA, Hamman RF. Sensory neuropathy in noninsulin-dependent diabetes mellitus. Am J Epidemiol 1990; 131:633–643.
Franklin GM, Shetterly SM, Cohen JA, Baxter J, Hamman RF. Risk factors for distal symmetric neuorpathy in NIDDM. Diabetes Care 1994;17:1172–1177.
Maser RE, Steenkiste AR, Dorman JS, et al. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 1989;38:1456–1461.
Maser RE, Nielsen VK, Bass EB, et al. Measuring diabetic neuropathy. Assesssment and comparison of clincial examination and quantitative sensory testing. Diabetes Care 1989; 12:270–275.
Orchard TJ, Dorman JS, Master RE, et al. Factors associated with avoidance of severe complications after 25 yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I. Diabetes Care 1990; 13(7):741–747.
Kriska AM, Laporte RE, Patrick SL, Kuller LH, Orchard TJ. The association of physical activity and diabetic complications in indiviuals with insulin-dependent diabetes mellitus: the Epidemiology of Diabetes Complications Study—VII. J Clin Epidemiol 1991;44: 1207–1214.
Harris M, Eastman R, Cowie C. Symptoms of sensory neuropathy in adults with NIDDM in the US population. Diabetes Care 1993; 16:1446–1552.
Knuiman MW, Welborn T, McCann VJ, Stanton KG, Constable IJ. Prevalance of diabetic complications in relation to risk factors. Diabetes 1986;35:1332–1339.
Walters DP, Gatling W, Mullee MA, Hill RD. The prevalence of diabetic distal sensory neuropathy in an English community. Diabet Med 1992;9:349–353.
Bergenheim T, Borssen B, Lithner F. Sensory thresholds for vibration, perception, and pain in diabetic patients aged 15–50 years. Diabetes Res Clin Practice 1992; 16:47–52.
Verhoeven S, van Ballegooie E, Casparie AF. Impact of late complications in Type 2 diabetes in a Dutch population. Diabet Med 1991;8:435–438.
Gregg EW, Sorlie P, Paulose-Ram R, et al. Prevalence of lower-extremity disease in the US adult population >40 years of age with and without diabetes. Diabetes Care 2004;27:1591–1597.
Savettieri G, Rocca WA, Salemi G, et al. Prevalence of diabetic neuropathy with somatic symptoms: a door-to-door survey in two Sicilian municipalities. Sicilian Neuro-Epidemiologic Study (SNES) Group. Neurology 1993;43:1115–1120.
Tesfaye S, Stevens LK, Stephenson JM, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetolgia 1996;39:1377–1384.
Anonymous, UK Prospective Diabetes Study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetes Res 1990;13:1–11.
Anonymous, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352(9131):837–853.
Tesfaye S, Chaturvedi N, Eaton SE, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med 2005;352:341–350.
Forrest KY, Maser RE, Pambianco G, Becker DJ, Orchard TJ. Hypertension as a risk factor for diabetic neuropathy. A prospective study. Diabetes 1997;46:665–670.
Adler AI, Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Smith DG. Risk factors for diabetic peripheral sensory neuropathy: results of the Seattle prospective diabetic foot study. Diabetes Care 1997;20:1162–1167.
Ewing JA. Detecting alcoholism: the CAGE questionnaire. JAMA 1984;252:1905–1907.
Dyck PJ, Davies JL, Wison DM, Service FJ, Melton LJ III, O’Brien PC. Risk factors for severity of diabetic polyneuropathy. Intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care 1999;22:1479–1486.
Sands ML, Shetterly SM, Franklin GM, Hamman RF. Incidence of distal symmetric (sensory) neuropathy in NIDDM. Diabetes Care 1997;20:322–329.
Loyd CE, Becker D, Ellis D, Orchard TJ. Incidence of complications in insulin dependent diabetes mellitus: a survival analysis. Am J Epidemiol 1996;143:431–441.
Partanen J, Niskanen L, Lehtinen J, Mersvaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995;333:89–94.
Klein R, Klein BE, Moss SE. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med 1996;124(1 pt 2):90–96.
Sosenko JM, Kato M, Soto R, Bild DE. A prospective study of sensory neuropathy in patients with Type 2 diabetes. Diabet Med 1993;10:110–114.
Reichard P. Risk factors for progression of microvascular complications in the Stockholm Diabetes Intervention Study (SDIS). Diabetes Res Clin Practice 1992;16:151–156.
Maser RE, Becker DJ, Drash AL, et al. Pittsburgh Epidemiology of Diabetes Complications Study. Measuring diabetic neuropathy follow-up study results. Diabetes Care 1992; 15: 525–527.
Hillson RM, Hockaday T, Newton DJ. Hyperglycemia is one correlate of deterioration in vibration sense during the 5 years after diagnosis of Type 2 (non-insulin-dependent) diabetes. Diabetolgia 1984;26:122–126.
Ziegler D, Mayer P, Muhlen H, Gries FA. The natural history of somatosensory and autonomic nerve dysfunction in relation to glycemic control during the first five years after the diagnosis of type 1 (insulin-dependent) diabetes mellitus. Diabetolgia 1991;34: 822–829.
Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1978;1:168–188.
Singh JP, Larson M, O’donnell CJ, et al. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol 2000;86:309–312.
Maser RE, Pfeifer M, Dorman JS, Kuller LH, Becker DJ, Orchard TJ. Diabetic autonomic neuropathy and cardiovascular risk. Pittsburgh Epidemiology of Diabetes Complications Study III. Arch Intern Med 1990;150:1218–1222.
Group, T.D.C.a.C.T.E.o.D.I.a.C.R. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann Intern Med 1995; 122:561–568.
Toyry JP, Niskanen LK, Mantysaari MJ, Lansimies EA, Uusitupa MIJ. Occurrence, predictors, and clinical significance of autonomic neuropathy in NIDDM. Ten year follow-up from diagnosis. Diabetes Care 1996;45:308–315.
Gaede P, Vedel P, Larsen N, Jensen G, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348: 383–393.
Dyck PJ, Kratz KM, Karnes JL, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993;43(4):817–824.
O’Hare JA, Abuaisha F, Geoghegan M. Prevalence and forms of neuropathic morbidity in 800 diabetics. Ir J Med Sci 1994;163(3):132–135.
Albers JW, Brown MB, Sima AA, Greene DA. Frequency of median mononeuropathy in patients with mild diabetic neuropathy in the early diabetes intervention trial (EDIT). Tolrestat Study Group For Edit (Early Diabetes Intervention Trial). Muscle Nerve 1996; 19(2): 140–146.
Perkins BA, Olaleye D, Bril V. Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care 2002;25(3):565–569.
de Krom MC, Kester AD, Knipschild PG, Spaans F. Risk factors for carpal tunnel syndrome. Am J Epidemiol 1990;132(6):1102–1110.
Solomon DH, Katz JN, Bohn R, Mogun H, Avorn J. Nonoccupational risk factors for carpal tunnel syndrome. J Gen Intern Med 1999;14:310–314.
Becker J, Nora DB, Gomes I, et al. An evaluation of gender, obesity, age and diabetes mellitus as risk factors for carpal tunnel syndrome. Clin Neurophysiol 2002; 113(9): 1429–1434.
Karpitskaya, Y, Novak CB, Mackinnon SE. Prevalence of smoking, obesity, diabetes mellitus, and thyroid disease in patients with carpal tunnel syndrome. Ann Plast Surg 2002;48(3): 269–273.
Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991;41(5):617–618.
Lunn MP, Manji H, Choudhary PP, Hughes RA, Thomas PK. Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry 1999;66(5):677–680.
McLeod JG, Pollard JD, Macaskill P, Mohamed A, Spring P, Khurana V. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol 1999;46(6):910–913.
Sharma KR, Cross J, Farronay O, et al. Demyelinating neuropathy in diabetes mellitus. Arch Neurol 2002;59(5):758–765.
Lozeron P, Nahum L, Lacroix C, Ropert A, Guglielmi JM, Said G. Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients. J Neurol 2002;249(5): 569–575.
McNeely MJ, Boyko EJ, Ahroni JH, et al. The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration. How great are the risks? Diabetes Care 1995;18(2):216–219.
Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med 1998; 158(2): 157–162.
Rith-Najarian SJ, Stolusky T, Gohdes DM. Identifying diabetic patients at high risk for lower-extremity amputation in a primary health care setting. A prospective evaluation of simple screening criteria. Diabetes Care 1992;15(10):1386–1389.
Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care 1994;17(6):557–560.
Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care 2000;23(5):606–611.
Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care 1999;22(7):1036–1042.
Eriksson KF, Nilsson H, Lindgarde F, et al. Diabetes mellitus but not impaired glucose tolerance is associated with dysfunction in peripheral nerves. Diabetes Med 1994; 11:279–285.